Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
AML IP v. Aveda Corp. — Electronic Commerce Token Patent | PatSnap
Explore in Eureka
Case ID6:24-cv-00572
FiledOct 2024
ClosedNov 2024
Patent Litigation

AML IP v. Aveda Corp.: Electronic Token Patent Suit Dismissed in 1 Day

AML IP, LLC filed suit against Aveda Corp. in the Western District of Texas asserting US7177838B1, a patent covering electronic token-based commerce transactions. The case was voluntarily dismissed without prejudice just one day after filing, before Aveda had answered or filed any motion, with each party bearing its own costs.

Resolution time
1days
Case closed 1 day after filing — among the shortest patent litigation lifecycles on record
Patents asserted
1
US7177838B1 — method and apparatus for conducting electronic commerce transactions using electronic tokens
Outcome
Voluntary dismissal
Voluntarily dismissed without prejudice — plaintiff retains right to refile on the same patent
Cost ruling
Own Costs
Each party bears its own costs, expenses, and attorneys’ fees — no fee-shifting ordered
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

A one-day patent suit: tactical filing or immediate retreat?

On October 31, 2024, AML IP, LLC — a non-practicing entity represented by Ramey LLP — filed a patent infringement action against Aveda Corp. in the Western District of Texas before Judge Fred Biery. The asserted patent, US7177838B1, covers a method and apparatus for conducting electronic commerce transactions using electronic tokens, a foundational e-commerce technology area with broad commercial relevance.

Just one day later, on November 1, 2024, AML IP filed a notice of voluntary dismissal pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). Because Aveda had neither answered the complaint nor filed a motion for summary judgment, AML IP was entitled to dismiss as of right without court approval. The dismissal was expressly without prejudice as to the asserted patent, meaning the claims survive and AML IP retains the ability to refile against Aveda or assert the same patent against other defendants.

A one-day duration is highly atypical even for pre-answer voluntary dismissals and suggests the filing may have served a purpose other than pursuing full litigation — possibly initiating licensing discussions, testing jurisdiction, or addressing an administrative issue. The public record does not disclose whether any pre-dismissal communication or agreement occurred between the parties, and the cost-bearing arrangement — each side absorbs its own fees — is standard for Rule 41(a)(1) dismissals and does not signal a negotiated resolution.

Case at a glance
Case no.6:24-cv-00572
PlaintiffAML IP, LLC
DefendantAveda Corp.
CourtTexas Western
JudgeFred Biery
FiledOctober 31, 2024
ClosedNovember 1, 2024
Duration1 days
OutcomeVoluntary dismissal
Verdict causeInfringement Action
BasisVoluntary dismissal
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Texas Western District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Voluntary dismissal in 1 days

Case closed 1 day after filing — among the shortest patent litigation lifecycles on record

Case timeline: Complaint filed OCT 31 2024, OCT–NOV — 1 days total Horizontal timeline showing the three key events in AML IP, LLC v Aveda Corp. from filing to resolution. Source: PACER, Texas Western District Court. OCT 31 2024 Complaint filed Pre-trial proceedings NOV 1 2024 Voluntary dismissal 1 DAYS TOTAL
Dismissal terms

Voluntarily dismissed without prejudice: what the record reveals

Legal mechanism

Rule 41(a)(1)(A)(i): dismissal as of right, no court order needed

Federal Rule 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without a court order by filing a notice before the opposing party serves an answer or a motion for summary judgment. AML IP invoked this right on day one. Because no judicial discretion is involved, this dismissal carries no ruling on the merits and creates no estoppel. The court record closes, but the legal dispute is not resolved.

No merits adjudication
Prejudice status

Dismissed without prejudice: the patent lives on

The notice expressly states the dismissal is without prejudice as to the asserted patent. This means AML IP may refile the same infringement claims against Aveda Corp. at any time within the applicable statute of limitations, or assert US7177838B1 against other parties. A without-prejudice dismissal under Rule 41(a)(1) does not bar future enforcement and should not be read as an admission of weakness in the patent’s validity or infringement theory.

Refiling risk remains
Defendant outcome

Aveda exits without liability — but exposure is not extinguished

Aveda Corp. benefits from an immediate exit with no judgment, no injunction, and no fee award against it. However, the without-prejudice dismissal means Aveda has not secured a definitive resolution. The patent remains in force, and AML IP retains full enforcement rights. Aveda should treat this dismissal as a pause rather than a conclusion and consider whether a proactive freedom-to-operate or invalidity analysis is warranted.

No final resolution for defendant
Commercial signal

One-day filings: a known NPE litigation tactic worth monitoring

Ultra-short patent cases filed and dismissed before any defendant response are consistent with several NPE strategies: initiating licensing pressure, testing forum selection, or resolving a pre-suit agreement quickly. The Western District of Texas remains a preferred venue for patent plaintiffs. Companies operating in the e-commerce and digital payments space with electronic token or transaction authentication functionality should monitor US7177838B1 and AML IP’s broader portfolio for re-assertion activity.

Monitor for re-assertion
Legal analysis based on PACER docket records for case 6:24-cv-00572 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffAML IP, LLCCompanyNon-practicing entity (NPE) — holder of US7177838B1 covering electronic token commerce methodsSearch in Eureka ↗
DefendantAveda Corp.CompanyAveda Corp. — professional beauty and personal care product companySearch in Eureka ↗
Plaintiff counselJeffrey Eugene KubiakAttorneyCounsel for AML IP, LLCSearch in Eureka ↗
Plaintiff counselWilliam P. Ramey , IIIAttorneyCounsel for AML IP, LLCSearch in Eureka ↗
Plaintiff law firmRamey LLPLaw FirmRepresenting AML IP, LLCSearch in Eureka ↗
Presiding judgeJudge Fred BieryJudgeTexas Western District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“Pursuant to Federal Rule 41 (a)(1)(A)(i), the Plaintiff, AML IP, LLC, files this notice of voluntary dismissal of this action for all of Plaintiff’s claims as defendant has not answered or filed a motion for summary judgment. The dismissal of Plaintiff’s claims shall be WITHOUT PREJUDICE as to the asserted patent. Each party shall bear its own costs, expenses and attorneys’ fees”
Source: PACER Docket, Case 6:24-cv-00572, Texas Western District Court

The dismissal notice tracks the precise language of Rule 41(a)(1)(A)(i), confirming the procedural basis and the without-prejudice designation for the asserted patent. The explicit cost-bearing clause — each party absorbs its own fees — is standard for this mechanism and does not indicate a negotiated financial resolution. Critically, no merits finding was made on infringement, validity, or claim scope, leaving the patent’s enforceability entirely intact.

PACER case 6:24-cv-00572 · Public docket record Explore in Eureka ↗
Patent at issue

US7177838B1 — Electronic Token-Based Commerce Transaction Method

Publication No.US7177838B1
Application No.US09/553695
Patent details
ProductMethod and apparatus for conducting electronic commerce transactions using electronic tokens
Cited in actionOctober 31, 2024

US7177838B1, filed under application number US09/553695, protects a method and apparatus for conducting electronic commerce transactions using electronic tokens. The patent sits within the foundational layer of digital payment infrastructure — covering the issuance, validation, and use of electronic tokens as a substitute or proxy for traditional payment credentials in online transaction flows. The application predates modern tokenisation standards, giving it a potentially broad priority date claim relative to widely deployed implementations.

From a competitive intelligence standpoint, this patent is strategically significant for any company operating tokenised payment, stored-value, or digital wallet functionality. The assertion against Aveda — a consumer-facing brand with e-commerce operations — suggests AML IP may be pursuing retail and direct-to-consumer platforms as targets. Fintech platforms, payment processors, and e-commerce enablers should assess whether their token-handling architectures fall within the claim scope of US7177838B1, particularly given the without-prejudice dismissal leaves enforcement fully open.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should your team run an FTO analysis against US7177838B1?

Any company operating electronic token-based transaction functionality — whether in digital wallets, loyalty point redemption, stored-value cards, or tokenised checkout flows — should assess its exposure to US7177838B1. The without-prejudice dismissal in this case means AML IP has signalled intent without closing the door. E-commerce platforms, payment service providers, and SaaS commerce companies are the most likely next targets, particularly those with high transaction volumes and recognisable consumer brands.

PatSnap Eureka’s FTO Search Agent enables product and IP teams to map claim language from US7177838B1 against their specific technology stack, identify prior art that may challenge patent validity, and surface any related continuation or family patents held by AML IP. Running this analysis proactively — before a demand letter or complaint arrives — positions your team to respond strategically rather than reactively, and informs whether a design-around, licence negotiation, or IPR petition is the most commercially efficient path.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US7177838B1 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar electronic token and e-commerce patent cases in W.D. Texas

Explore related NPE-asserted electronic commerce and digital token patent cases filed in the Western District of Texas, including comparable Rule 41 dismissal patterns.

🔍
Access 40+ similar cases in PatSnap Eureka
AML IP, LLC patent enforcement history, Texas Western case history, AML IP, LLC’s full IP portfolio, and comparable case analysis
Related AML IP filingsRamey LLP NPE campaignsW.D. Texas e-commerce suitsElectronic token patent assertions
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the e-commerce patent IP landscape

A one-day filing-to-dismissal cycle in W.D. Texas rarely signals closure. For e-commerce technology companies, the risk profile here warrants attention.

Without-prejudice dismissals reset the clock — not the risk

AML IP retains full rights to refile against Aveda or any other party. Companies offering electronic transaction, token-based authentication, or digital payment features should audit their exposure to US7177838B1 now, not after a second filing arrives. A proactive invalidity or design-around analysis costs a fraction of litigation response.

W.D. Texas remains a high-velocity NPE venue — even 1-day cases matter

The Western District of Texas under Judge Biery continues to attract NPE filings. Even cases closed in a single day generate a public docket entry that can anchor future licensing demand letters. In-house teams should flag any W.D. Texas complaint in their technology space regardless of immediate resolution, as the filing itself has strategic value for the plaintiff.

🔒
Full strategic analysis in PatSnap Eureka
Unlock deeper analysis on e-commerce token patent risk and NPE assertion trends in the W.D. Texas district court.
Patent claim scope mappingRamey LLP filing patternsAML IP portfolio exposure
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

AML v Aveda — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Don’t wait for the refile — run your e-commerce patent FTO now

AML IP’s without-prejudice dismissal keeps US7177838B1 fully live. PatSnap Eureka helps you map your token-based transaction architecture against active patent claims and monitor for new filings before a demand letter arrives.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.